TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
NRXS

Neuraxis, Inc.

Healthcare · Biotechnology

7.10$ -3.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow NRXS
Line item 2020 2021 2022 2023 2024 2025
-214.4% -82.1% -85.6% -272.1% -227.0% -180.2%
1.9% 1.3% 1.4% 1.7% 1.4% 1.7%
2.5% 1.8% 1.0% 30.5% 52.3% 16.7%
-8.0% 4.1% – – – –
-15.3% 23.7% 47.3% -27.1% 5.3% 17.1%
1.4% 0.1% 2.3% 2.9% 1.0% 0.9%
-1.4% -0.1% -2.3% -2.9% -1.0% -3.7%
-37.1% 5.6% 117.7% 84.0% 173.5% -7.9%
313.6% 24.3% 85.4% 267.9% 362.8% 219.4%
97.8% -57.9% -2.5% -7.1% 134.7% 35.5%
-215.9% -82.2% -87.9% -275.0% -228.1% -181.1%

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?